“Addressing a global health threat such as this newest coronavirus is going to take a collaborative effort, which is why we are working with BARDA to quickly advance a potential vaccine candidate,” Global Head of Vaccines at Sanofi David Loew said in a statement.
While the company is lending its expertise where possible, it believes the collaboration with BARDA may provide the most meaningful results in protecting the public from this latest outbreak, he added.
COVID-19 is a respiratory disease due to novel coronavirus.
In late-2002, the SARS (severe acute respiratory syndrome) coronavirus emerged and then largely disappeared by 2004.
Sanofi plans to further investigate an advanced pre-clinical SARS vaccine candidate that could protect against COVID-19.
The company said it will use its recombinant DNA platform to produce a 2019 novel coronavirus vaccine candidate.
The recombinant technology produces an exact genetic match to proteins found on the surface of the virus.
“Emerging global health threats like the 2019 novel coronavirus require a rapid response,” BARDA Director Rick A Bright said.
He further said: “By expanding our partnership with Sanofi Pasteur and leveraging a licensed recombinant vaccine platform, we hope to speed development of a vaccine candidate to protect against a new virus.”
In December 2019, Sanofi had also entered into an agreement with BARDA to establish facilities in the US for the sustainable production of an adjuvanted recombinant vaccine for use in the event of an influenza pandemic and based on the same technology platform that will be used for the COVID-19 programme.
So far, around 2,000 people, mainly in mainland China, have lost their lives after falling sick due to the outbreak of the coronavirus.
- 'Big pharma' urged to develop treatments for global health
- ED SEEKS INFO ON MULTI-CRORE SCHOLARSHIP SCAM FROM MAHA GOVT
- Govt funds gained for museum projects
- Kim Jong-un like young Gorbachev in N. Korea – South’s govt adviser
- Badgers to undergo £48k vaccine scheme
- Explainer: What is the UN Global Migration Compact that New Zealand could join?
- FT Health: Progress stalls in fight against malaria
- Animal Lovers Rally to Save 'Avni' India's Most Feared Man-Eater Tigress
- Life Sciences Success Stories in Hungary
- POLITICO London Playbook, presented by London City Airport: Beers in the Grand Place — Deadlock continues — One. More. Year.
- POLITICO London Playbook: May’s Brexit dilemma — Barnier speech in Brussels — Hammond budget grilling
- How the poetry of men who loved men helped shape our understanding of the First World War
- How to enter the Cambridge News Business Excellence Awards 2019
- Siblings raising money for educational trip to Africa
- Fiona conquers her fear – and flies high
- Timeline of Harry and Meghan’s relationship
- Interview: Billy Steele on turning Flower of Scotland into our anthem
- Kurds Have Been Preparing for Trump’s Syria Betrayal—With a Vengeance
- Brexit latest: Theresa May faces Cabinet backlash and threat to Premiership as she reveals new deal
- Brexit latest news: Theresa May should go back to Brussels to renegotiate or be replaced, Tory MP says
Sanofi joins hands with US govt to expedite development of coronavirus vaccine have 534 words, post on economictimes.indiatimes.com at February 19, 2020. This is cached page on Europe Breaking News. If you want remove this page, please contact us.